KB801

· Krystal Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KB801, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis [Phase 1, Phase 2]